Initial Experiences with the Impella Device in Patients with Cardiogenic Shock

Abstract

Background: We planned a study to assess the safety, feasibility, and efficacy of the Impella® micro-axial blood pump in patients with cardiogenic shock. Methods: From January 2001 to September 2002 inclusive, 16 patients in cardiogenic shock (maximal inotropic support and with IABP in 11 cases) underwent left ventricle unloading with the Impella® pump. 6 were placed via the femoral artery (patients in the coronary care unit) and 10 directly through the aorta (postcardiotomy heart failure). In three patients, the device was used in combination with ECMO. Mean age was 60 years (range 43 - 75), 11 were male. Results: A stable pump flow of 4.24 ± 0.28 l/min was reached (3.3 ± 1.9 l/min in patients with ECMO and Impella). Mean blood pressure before Impella® support was 57.4 ± 13 mmHg, which increased to 74.9 ± 13 mmHg after 6 hours and 80.6 ± 17 mmHg (p = 0.003) after 24 hours. Cardiac output increased from 4.1 ± 1.3 l/min to 5.5 ± 1.3 (p = 0.003) and 5.9 ±1.9 l/min (p = 0.01) at 6 and 24 hours. Mean pulmonary wedge pressure decreased from 29 ± 10 mmHg to 17 ± 5 mmHg and 18 ± 7 mmHg at 6 (p = 0.04) and 24 hours. Blood lactate levels decreased significantly after 6 hours of support (from 2.7 ± 1 to 1.3 ± 0.5 mmol/l, p = 0.004). Device-related complications included three sensor failures (no clinical action), one pump displacement (replacement) and six incidences of haemolysis (peak free plasma haemoglobin > 100 mg/dl, no clinical action). Eleven patients (68 %) were weaned, six (37 %) survived. Conclusions: Left ventricular unloading with the Impella® pump via the transthoracic or femoral approach is feasible and safe. Support led to a decrease in pulmonary capillary wedge pressure, increase in cardiac output and mean blood pressure, and improved organ perfusion in patients with severe cardiogenic shock.

Cardiogenic shock - mechanical support - Impella

References

• 1 Resnekov L. Cardiogenic shock.  Chest. 1983;  83 893-898
• 2 The GUSTO Investigators . An international randomised trial comparing four thrombolytic strategies for acute myocardial infarction.  N Eng J Med. 1993;  329 673-682
• 3 Goldberg R J, Gore J M, Alpert J S. et al . Cardiogenic shock after acute myocardial. Incidence and mortality from a community-wide perspective, 1975 to 1988.  N Engl J Med. 1991;  325 1117-1122
• 4 Kovack P, Rasak M A, Bates E R, Ohman E M, Stomel R J. Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock.  J Am Coll Cardiol. 1997;  29 1454-1558
• 5 Lee C, Bates E, Pitt B. et al . PTCA improves survival in acute myocardial infarction complicated with cardiogenic shock.  Circulation. 1998;  78 1345-1351
• 6 Hochman J S, Sleeper L A, Godfrey E. et al . for the SHOCK trial study group Should we emergently revascularise occluded coronary arteries for cardiogenic shock: an international randomised trial of emergency PTCA/CABG design.  Am Heart J. 1999;  137 313-321
• 7 Meyns B, Sergeant P, Wouters P, Casselman F, Herijgers P, Daenen W, Bogaerts K, Flameng W. Mechanical support with microaxial blood pumps for postcardiotomy left ventricular failure: can outcome be predicted ?.  J Thorac Cardiovasc Surg. 2000;  120 393-400
• 8 Meyns B, Nishimura Y, Racz R, Jashari R, Flameng W. Organ perfusion with hemopump device assistance with and without intraaortic balloon pumping.  J Thorac Cardiovasc Surg. 1997;  114 243-253
• 9 Smalling R W, Cassidy D B, Barrett R. et al . Improved regional myocardial bloodflow, left ventricle unloading, and infarct salvation using axial-flow, transvalvular left ventricle assist device. A comparison with intra-aortic balloon counterpulsation and reperfusion alone in a canine infarction model.  Circulation. 1992;  85 1152-1159
• 10 Meyns B, Sergeant P, Nishida T, Perek B, Zietkiewicz M, Flameng W. Micropumps to support the heart during CABG.  Eur J Cardiothorac Surg. 2000;  17 169-174
• 11 Laschinger J C, Grossi E A, Cunningham J N. et al . Adjunctive left ventricular unloading during myocardial reperfusion plays a major role in minimizing myocardial infarct size.  J Thorac Cardiovasc Surg. 1985 ;  90 80-85
• 12 Pae W. Ventricular assist devices and total artificial hearts: a combined registry.  Ann Thorac Surg. 1993;  55 295-298
• 13 Noon G P, Ball J W, Short H D. Bio-Medicus centrifugal ventricular support for postcardiotomy cardiac failure: a review of 129 cases.  Ann Thorac Surg. 1996;  61 291-295
• 14 Casimir-Ahn H, Lönn U, Peterzen B. Clinical use of the Hemopump cardiac assist system for circulatory support.  Ann Thorac Surg. 1995;  59 S39-45
• 15 Meyns B, Autschback R, Böning A, Konertz W, Matschke K, Schöndube F, Wiebe K, Fischer E. Coronary artery bypass grafting supported with intracardiac microaxial pumps versus normothermic cardiopulmonary bypass: a prospective randomised trial.  Eur J Cardiothorac Surg. 2002;  22 112-117
• 16 Mueller X M, Boone Y, Augstburger M, Horisberger J, von Segesser L K. Bi-ventricular axial micropump: impact on blood cell integrity.  Swiss Surg. 2001 ;  7 213-217
• 17 Baskett R J, Ghali W A, Maitland A, Hirsch G M. The intraaortic balloon pump in cardiac surgery.  Ann Thorac Surg. 2002;  74 1276-1287
• 18 Arafa O, Pedersen T, Svennevig J, Fosse E, Geiran O. Intraaortic balloon pump in open heart operations: 10 year follow-up with risk analysis.  Ann Thorac Surg. 1998;  65 741-747
• 19 Baldwin R T, Slogoff S, Noon G P. et al . A model to predict survival at time of postcardiotomy intraaortic balloon insertion.  Ann Thorac Surg. 1993;  55 908-913
• 20 Hausmann H, Potapov E V, Koster A, Krabatsch T, Stein J, Yeter R, Kukucha M, Sodian R, Kuppe H, Hetzer R. Prognosis after the implantation of an intra-aortic balloon pump in cardiac surgery calculated with a new score.  Circulation. 2002;  106 1203-1206